Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

The endocrine renin-angiotensin system (RAS) is a key regulator of the autonomic nervous system and blood pressure (BP). Research over the past 5 decades has demonstrated that, in addition to this, circulating RAS tissues, including in the brain, express RAS components and have the capacity to generate and respond to angiotensin peptides. Recently, compelling new data have indicated the presence of renin expression within a discrete neuronal population in the nucleus ambiguus (NuAm), a brainstem region traditionally associated with parasympathetic control of heart rate (HR). These findings challenge conventional perspectives on brain RAS function and raise critical questions about its role in autonomic regulation. Here we provide a review of recent studies characterizing the NuAm and the adjacent C1 region of the rostral ventrolateral medulla (RVLM)-a key vasomotor center linked to sympathetic outflow. We revisit the hypothesis that the NuAm may influence BP and HR through both parasympathetic and sympathetic pathways through interactions with the RVLM. Furthermore, we highlight an emerging trend of sex-dependent differences in brain RAS activation. Finally, we emphasize the need for targeted molecular and physiological investigations to clarify the interplay between the NuAm and RVLM, their respective contributions to autonomic balance, and the potential involvement of brain RAS dysfunction in neurogenic hypertension.

Download full-text PDF

Source
http://dx.doi.org/10.1210/endocr/bqaf134DOI Listing

Publication Analysis

Top Keywords

brain ras
12
ras
6
physiological molecular
4
molecular implications
4
implications angiotensinergic
4
angiotensinergic signaling
4
signaling brainstem
4
brainstem endocrine
4
endocrine renin-angiotensin
4
renin-angiotensin system
4

Similar Publications

Background: Glioblastoma (GBM) is an extremely aggressive brain tumor, marked by restricted therapeutic possibilities and a generally unfavorable prognosis. GBM's complexity and heterogeneity necessitate comprehensive genetic and immunological profiling to enhance therapeutic strategies.

Methods: The study integrated The Cancer Genome Atlas (TCGA) and Integrative Epidemiology Unit Open Genome-Wide Association Studies (IEU OpenGWAS) data to identify genetic factors influencing GBM using expression quantitative trait loci (eQTL) and genome-wide association studies (GWAS).

View Article and Find Full Text PDF

Introduction: Treatment-Resistant Depression (TRD) is a complex clinical condition characterized by inadequate response to conventional antidepressant treatments. There is growing evidence that microRNAs (miRNAs) play a role in the underlying pathophysiology of TRD and may offer new avenues for diagnostics and therapy.

Methods: A structured literature review of peer-reviewed publications indexed in PubMed, Scopus, and Web of Science was conducted.

View Article and Find Full Text PDF

Background: -mutant gliomas can be targeted therapeutically using BRAF-selective inhibitors, yet responses are often transient due to adaptive resistance through reactivation of RAS-ERK signaling. Here, we evaluate the role of SHP2, a central regulator of RAS activity, and SHP2 inhibitors in overcoming resistance to BRAF inhibitors in glioma.

Methods: RNAseq and protein expression in human tissue samples and glioma cell lines were used to identify resistance mechanisms.

View Article and Find Full Text PDF

Mutations in the GBA1 gene, encoding the lysosomal enzyme glucocerebrosidase (GCase), and the LRRK2 gene, encoding leucine-rich repeat kinase 2 (LRRK2) are the most common genetic risk factors for Parkinson's disease (PD). The potential use of LRRK2 inhibitors for treating not only LRRK2-associated PD (LRRK2-PD) but also GBA1-associated PD (GBA1-PD) is currently under discussion. In the present study, we aimed to evaluate whether LRRK2 inhibition affects lysosomal hydrolase enzymatic activities, autophagy, and alpha-synuclein levels in various cell types derived from LRRK2-PD and GBA1-PD patients, including macrophages derived from peripheral blood mononuclear cells (PBMC-derived macrophages), dopaminergic (DA) neurons derived from induced pluripotent stem cells (iPSC-derived DA neurons), and SH-SY5Y cells.

View Article and Find Full Text PDF

Direct and paracrine neuron-cancer interactions govern tumor development and progression. While neuron-elaborated neurotransmitters, like glutamate, support neoplastic growth, the mechanism underlying tumor intracellular mitogenic signaling and proliferation remains an unresolved question in cancer neuroscience. Herein, we discover that glutamate receptor (GluR) stimulation phosphorylates sarcoma proto-oncogene (Src) to activate platelet-derived growth factor (PDGF) receptor-α (PDGFRα)-dependent extracellular-regulated kinase (ERK) signaling and drive glioma growth.

View Article and Find Full Text PDF